Overexpression of ABCB1 in breast cancer is associated with poor response to first-line chemotherapies because ABCB1 can efflux many drugs used in the treatment of breast cancer such as taxanes, anthracyclines, and vinca alkaloids [35]. This evidence concerns the gene ABCB1 and breast carcinoma.